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ABSTRACT
There is a physiological basis for the roles of selected nutrients, especially proteins, calcium, and vitamin D, in growth and development, which are
at a maximum during the pediatric period. Milk and dairy products are particularly rich in this group of nutrients. The present systematic review
summarizes the available evidence relating dairy product intake with linear growth and bone mineral content in childhood and adolescence. A
search was conducted in the MEDLINE (via PubMed) and SCOPUS databases following Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines and included intervention-controlled clinical trials with dairy products in children from 1 January, 1926 to 30 June,
2018. The risk of bias for each study was assessed using the Cochrane methodology. The number of study participants, the type of study and
doses, the major outcomes, and the key results of the 13 articles included in the review are reported. The present systematic review shows that
supplementing the usual diet with dairy products significantly increases bone mineral content during childhood. However, the results regarding a
possible relation between dairy product consumption and linear growth are inconclusive. Adv Nutr 2019;10:S88–S96.
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Introduction
The relation between milk consumption during the pediatric
age period and increased linear growth and bone mineral-
ization has been widely hypothesized since the 1920s (1).
In addition to fetal development, the pediatric period is
when the largest and fastest growth and development occur.
This growth is continuous, with rate changes throughout
childhood, i.e., accelerated growth during early childhood,
stable growth during the preschool and school years, and
accelerated growth during puberty (2). Height and bone
mineral content (BMC) are known growth markers. Linear
growth and bone acquisition are 2 different physiologic
processes that do not occur exactly at the same time, although
they are related (3). Skeletal mineralization begins during
fetal development and continues at different rates until the
end of the teenage years. At this point, 90–95% of the total
peak bone mass has been reached, of which 40–45% develops
during adolescence (4–7). McCormack et al. (3) studied a
group of 2014 boys and girls and observed that at 7 y of
age they had acquired between 69.5% and 74.5% of their
adult height and only between 29.6% and 38.1% of their
maximum BMC. At the time of their peak height velocity,
these children had acquired almost 90% of their adult height
and 57.6–60.2% of their maximum BMC. They also observed
that between 6.9% and 10.7% of peak bone mass is gained in
late adolescence, after the cessation of linear growth.
Genetic factors, sometimes mediated by hormonal factors,
determine ∼70–80% of linear growth and acquisition of
BMC (8–10), whereas environmental factors determine
∼20–30%, especially physical activity (11–13), inactivity and
sedentarism, and diet (14–17). These exogenous factors are
susceptible to change.
Regarding physical activity, it is shown that exercise
improves muscle strength, cartilage preservation, and bone
remodeling (18, 19). Studies in rat models (20, 21) and
clinical trials in osteoporotic patients (18, 19) confirm that
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aerobic activity plus resistance or strength exercises (like
whole body vibration training) are a great tool for improving
bone mass.
In relation to the diet, understanding the roles of different
food systems and patterns is important for establishing pre-
vention and intervention strategies. Physiology justifies milk
and dairy product consumption during the pediatric period,
because they are good sources of energy, macronutrients, and
micronutrients (proteins, phosphorus, magnesium, vitamin
D, and, most importantly, calcium) for growth and devel-
opment (15, 16). In addition, prospective clinical studies
have shown that calcium supplementation can increase the
acquisition of bone mass during childhood, adolescence,
and early adulthood (17, 22). There is a threshold in the
calcium intake, which if exceeded does not affect the bone
mass, but if the consumption is below the threshold it results
in a negative balance. The level of this threshold depends
on the ability to absorb calcium efficiently and decrease
urinary losses and varies according to age, ethnic group, and
genetic factors (23). Moreover, dairy product consumption
increases the secretion of insulin-like growth factor type I,
which benefits skeletal development (24). Likewise, dairy
products are thought to aid in calcium absorption because
of their lactose and casein phosphorylated peptides and
because they allow calcium intake to be more homogeneously
distributed in relatively small amounts throughout the day
(25). Currently, in developed countries, children under the
age of 9 y are recommended to use ∼500 mL dairy products
and adolescents >600 mL dairy/d (26).
Since the first studies on dietary supplementation with
milk (1), the scientific community has continued to study
its potential benefit, with the goal of adopting public health
policies to optimize pediatric growth and development (27–
29). The development of dual-energy X-ray absorptiometry
(DXA) equipment since the 1960s has allowed for evaluating
BMC as well as density in growth studies (30). This
technique showed that children worldwide could improve
their bone mass peak via calcium or milk supplementation
(14, 27, 31). However, these findings were inconclusive. Two
meta-analyses performed by Huncharek et al. (32) in 2008
and Beer (33) in 2012 shed light on this topic. However,
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current evidence on the association of dairy product con-
sumption with growth and BMC has not been synthesized.
Therefore, the present systematic review carried out an
updated evaluation of the available evidence from clinical
trials that correlate dairy product intake with linear growth
and BMC in the pediatric population.
Methods
The present review was prepared following the guidelines
for Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) (34) and was registered in the
International Prospective Register of Systematic Reviews
(PROSPERO) as CRD42018100083. The PICOS criteria
(Population, Intervention, Comparison, Outcomes, Settings)
(35) were used (Table 1) to elaborate the following review
question: does the intake of dairy products influence linear
growth and BMC in children and adolescents? Controlled
intervention studies that evaluated dairy product intake and
its relation with BMC and height in children and adolescents
were incorporated.
Inclusion and exclusion criteria
Children and adolescents ≤18 y of age and of any ethnic
origin were included. Controlled studies, randomized or
not, published from 1 January, 1926 to 30 June, 2018,
were incorporated into the review. Studies that used dairy
fractions, did not include linear growth or BMC data, or did
not compare a control group without dairy products were
excluded.
Intervention types
Studies in which the interventions were performed with
complete dairy products (not fractions) and were compared
with a nonsupplemented group were included. The articles
were not restricted by time, type, or amount of dairy in the
intervention.
Primary outcome measures
Height in centimeters and changes in height after the inter-
vention in centimeters, centimeters per year, or percentage
were included as valid measures for linear growth analysis.
To evaluate bone mineralization, the BMC in grams and
its modifications in grams per year or percentage were
considered.
TABLE 1 PICOS criteria (35) for including studies that evaluate the




Intervention Controlled dairy intake
Comparison Control
Outcome Height and BMC
Setting Controlled trials
1BMC, bone mineral content.
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FIGURE 1 Flow diagram of the literature search process.
Literature search
The PUBMED and SCOPUS databases were searched using
the Medical Subject Heading (MeSH) terms “dairy products,”
“growth,” “development,” “bone density,” and “height.”
In PUBMED the following search strategy was used:
“Dairy products” (All Fields) AND [“Growth and develop-
ment” (All Fields) OR “Growth” (All Fields) OR “devel-
opment” (All Fields) OR “bone density” (All Fields) OR
“body height” (All Fields)] AND {“humans” [MeSH Terms]
AND [“infant” (MeSH Terms) OR “child” (MeSH Terms)
OR “adolescent” (MeSH Terms)]}. SCOPUS was searched
using the following formula, excluding from the results
the studies indexed in MEDLINE and those on animals:
“Dairy products” AND (“Growth and development” OR
“Growth” OR “development” OR “bone density” OR “body
height”).
Study selection
Independently, 2 authors (MJdC and CdL) selected the
studies from the 56 articles reviewed in full. RL, MLC, AG,
and MG-C arbitrated the discrepancies when no consensus
on the selection was reached. Finally, 13 articles (36–48) were
included in the systematic review.
Data extraction
Two investigators separately extracted the following data
from each study: publication year, number of participants by
sex, age, study type, intervention characteristics and study
duration, and outcomes and conclusions. RL moderated any
discrepancies.
Assessment of risk of bias
Two evaluators independently studied the risks of bias
following the methodology of the Cochrane Collaboration
(49). The articles were analyzed individually, and their risk
of bias was classified as high, uncertain, or low depending
on random sequence generation (selection bias), allocation
concealment (selection bias), blinding of participants and
personnel (performance bias), blinding of outcome assess-
ment (detection bias), incomplete outcome data (attrition
bias), and selective reporting (reporting bias). The presence
of other additional biases was also analyzed. In cases with a
disparity of opinions, a third reviewer arbitrated.
Results
Figure 1 shows the results of each step of the bibliographic
search. Of the 1038 results from the first search (PUBMED,
448; SCOPUS, 581; and other sources, 9), 6 duplicate articles
and 976 after review of the abstract were eliminated. Fifty-six
articles were considered for evaluating the full text. Finally, 13
articles that met the inclusion criteria were included in this
systematic review (36–48).
Tables 2 and 3 present the main characteristics of the
selected clinical trials. The publication dates covered 1926
to 2017, with 7 articles published after 2000. The articles in
this review included 3895 children and adolescents (63.67%
female). In 5 of these studies (38, 40, 43–45), only girls
participated. The sample sizes ranged from 47 to 757
participants, with a mean ± SD of 299 ± 234 participants.
The mean age was 9.95 y, ranging from 3 to 18 y. Five articles
(36, 38, 39, 43, 46) performed interventions using dairy
products (between 0.9 and 1.2 g of calcium-equivalent doses
per day) and the other 8 studies exclusively used milk. The
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intervention period ranged from 14 wk for Morgan et al.’s
(48) study in 1926 to 24 mo for those of Merrilees et al.
(43), Du et al. (40), and Cheng et al. (38), with a median
intervention period of 16 mo.
Dairy intake and height
All studies included in the review provided linear growth
data (Table 2). Six studies showed significant changes in
height adjusted for age (which relates the height with
that corresponding to the age of the child in a reference
population) or percentage change in height favoring the
intervention group (37, 39, 40, 42, 46, 47). Among these,
Grillenberger’s study (42) found significant differences in z-
score changes for height adjusted for age, but only in patients
who were short in stature for their age at the baseline.
The remaining articles showed no statistically significant
differences in height after the intervention (36, 38, 41, 43–45,
48). Four (38, 43–45) of the 5 articles that included only girls
(38, 40, 43–45) found no statistically significant differences
in height; however, in the studies that included both boys
and girls, 5 (37, 39, 42, 46, 47) of 8 (36, 37, 39, 41, 42, 46–
48) found significant differences in height. Nevertheless, the
studies that analyzed the subgroups by sex demonstrated no
significant differences in height change between the sexes
(36, 37, 39, 41, 42, 46–48). None of the articles that used
dairy products rather than milk (36, 38, 39, 43, 48) showed
significant differences favoring the intervention in height. In
addition, the study with dairy products published by Vogel et
al. (36) concluded that individuals in the intervention group
grew significantly less than those in the control group.
Dairy intake and BMC
Changes in BMC were evaluated in 7 articles (36, 38, 40, 41,
43–45) (Table 3). BMC was assessed by DXA in all of them.
All articles included data on total body BMC (36, 38, 40, 41,
43–45); 4 of the 7 studies (36, 38, 41, 43) included femur
determinations, 2 total femur (36, 46), 1 femoral neck (41),
and 1 femoral neck and trochanter (43); and 3 (38, 41, 43)
included column measurements, 1 total (41), and 2 (38, 43) of
the lumbar spine. One study included measurements in total
hip (41) and another in radius and tibia (36). Six articles (36,
40, 41, 43–45) found significant differences in BMC levels:
total BMC (40, 44, 45), tibia (36), total hip (41), or trochanter
(43). One of these studies, which recruited 10- to 12-y-old
girls, found no significant differences in total body, total
femur, or lumbar spine BMC after the intervention. However,
statistically significant differences in bone mineral density
were found at the femur level (38).
Assessment of risk of bias
Fifty-four percent of the articles presented low risks of
selection bias (random sequence generation) and attrition
bias (incomplete outcome data); 25% had low risks of
performance bias (blinding of participants and personnel)
and detection bias (blinding of outcome assessment). In 77%
of the articles, the risk of information bias (reporting bias)
was uncertain, because they published nonsignificant data.
The risk of selection bias (allocation concealment) was high
in all participating articles. A high risk of attrition bias was
considered when there were no references in the study to
the data lost during the intervention and an evaluation of
whether they were relevant, when the proportion of missing
data was sufficient to have a clinically significant effect, or the
methods of imputation for the treatment of missing data were
used inappropriately. Other risks of bias included a short
intervention time (48) of 14 wk and stratification through
self-reported physical activity level questionnaires (38).
The article published by Lien et al. (37) presented the
lowest risk of bias, although its mechanism of random
assignment by collectivities and not individuals implies a
significant risk of bias. The studies with the highest risks of
presenting biased results were those of Morgan et al. (48) and
Grillenberger (42). Additional information on the risk of bias
analysis (a risk of bias graph and summary) of the analyzed
articles is included in Supplemental Figures 1 and 2.
Discussion
The present systematic review of controlled trials on the
effects of dairy product consumption on linear growth and
BMC during the pediatric period shows that supplementing
the usual diet with these foods significantly increases BMC.
However, the results regarding a possible relation between
dairy product intake and height are inconclusive.
Regarding the impact of dairy consumption on linear
growth, 6 studies (37, 39, 40, 42, 46, 47) revealed statistically
significant increases in the sizes of children whose ages
ranged from 3 to 10 y. Five of these studies had the largest
sample sizes, between 454 and 757 participants (37, 39, 40, 42,
46). However, 7 studies observed no significant differences
(36, 38, 41, 43–45, 48), although the sample size was very
low in 5 of them (43–45, 47, 48), 105, 82, 48, 86, and 47
participants, respectively, which could decrease the statistical
power of the data analysis, and these included older children
(9–18 y of age). Therefore, the linear growth rates, amount
of milk supplemented (specifically calcium), and duration
of the intervention were too heterogeneous to draw firm
conclusions. These inconclusive results are consistent with
the scientific literature that assesses the relation between
calcium supplementation (the main micronutrient in milk
involved in bone metabolism) and bone length, which has
not evidenced a clear benefit of calcium intake on size
during growth periods (15, 16, 24). In 2011, a meta-analysis
was published addressing this question, which suggested an
additional 0.4 cm/y increase in height for every 245 mL of
milk consumed per day, although the degree of evidence
was considered of moderate quality because most of the
included studies presented serious limitations in their design
and execution (33).
In selected populations with high malnutrition indexes
(40, 42) and mainly vegetarian diets, an increased final
size was observed after dairy product supplementation,
which could be explained by the contributions of additional
energy and high-biological-value proteins. One group (42)
evidenced this effect specifically in the subset of children who
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started with a lower height-for-age z score at the beginning
of the intervention, which could support this hypothesis,
although this may not have been adequately explored in
the articles cited. Nevertheless, 1 cohort study by Marshall
et al. (31), not included in the review, also suggested a
relation between milk consumption and height increase,
although in this case the children who participated belonged
to families of medium socioeconomic status, with low
risks of malnutrition. However, this relation was nonlinear;
therefore, the mechanism that could explain the beneficial
effect could not be attributed exclusively to this dietary
measure but may link to a more favorable environment
involving other unevaluated factors. In this sense, recent
studies (50, 51) relate dairy product consumption to a
healthier diet. Thus, a study conducted in Australia in 2012
on 222 children between 8 and 10 y old and involving 3 food
recalls concluded that adequate dairy product consumption
was associated with highly nutritious diets (50). Moreover,
1 study followed 1991 children from 8 European countries for
4 y and concluded consuming dairy products (milk, yogurt,
and cheese) as snacks is associated with higher diet quality.
Consuming dairy products outside of regular meals may be
a good strategy for improving energy balance throughout
childhood (51).
Regarding bone mineralization and dairy product con-
sumption, 7 controlled trials were evaluated (36, 38, 40, 41,
43–45), of which 6 (36, 38, 41, 43–45) were randomized.
Six of the 7 mentioned studies, 1 nonrandomized, showed
positive relations with bone mineralization (36, 40, 41, 43–
45), although this was measured in different locations: 3 at
the total body level (40, 44, 45), 1 in the pelvis (41),
1 in the trochanter (43), and 1 in the tibia (36). These
results were consistent with other investigations, which,
conversely, studied the effect of avoiding milk consumption
for prolonged periods. Black et al. (52) recruited 50 children
between 3 and 10 y of age, who, for different reasons, ingested
no milk (lactose intolerance or lifestyle) and observed that
these children had significantly lower bone mineral densities
and more fractures than did controls that consumed 200 mL
of milk daily. However, the blood calcium concentrations
in this group were lower, as an association between these
concentrations and the z scores, as shown by DXA, was
found only at some skeletal sites, suggesting that intakes of
both calcium and other nutrients in milk are essential to
properly mineralize bones. Studies supporting the benefits
of milk or dairy products on bone show a significant
inverse association between dairy food intake and bone
turnover markers as well as a positive association with BMC
(25, 53).
One study in the present systematic review further
explored this hypothesis by comparing the effect of calcium
supplementation on girls between 10 and 12 y old, either by
administering pills or by increasing cheese intake (38). Both
measures increased bone mass compared with the placebo,
and this effect was greater in the group that received the
food, although it was only statistically significant at the level
of the tibial cortical bone. In addition, studies conducted on
adults have also supported the hypothesis that dairy products
ingested during childhood improve bone mineralization, and
adults who consumed more milk in childhood had better
bone density (17, 22).
However, demonstrating the true effects of improved
BMC on individual health has not been possible. A 22-y
prospective observational study concluded that high dairy
intake during adolescence did not appear to prevent bone
fractures in women during adulthood. In men, it appeared
to be more of a risk factor, although the association was
attenuated when weight was added to the model (54).
Although observational studies only suggest hypotheses, and
multiple factors influence the risk of fractures, knowing the
long-term results of dairy supplementation interventions
would be interesting. Likewise, the studies included in this
review seemed to have short intervention times (between
14 wk and 2 y) compared with a study that evaluated dairy
intake over 5 y (54).
Regarding sex, the present review found that studies on
girls obtained less significant results for height than did those
on both boys and girls, but studies using both sexes showed
no differences between the sexes. Some cohort studies that
included both boys and girls found statistically significant
differences in height relative to dairy intake but also found
no differences between subgroups by sex (31, 55). However,
a study on height in adult males from 48 European countries
found that the ratio of high-quality protein intake, especially
from dairy products, to low-quality proteins from wheat was
the most important factor in the secular improvement of
height (56). Therefore, more studies including men or larger
studies including both sexes should be designed to better
evaluate the possible differences.
In the present review, we analyzed evidence from the
last 92 y of intervention studies on the effect of milk and
dairy products on linear growth and BMC in children. When
evaluating the risk of bias in each of the studies and assessing
their results, not all biases should be considered equally
relevant. For example, for the intervention characteristics
and results evaluated, we believe that performance bias is
less important because height and BMC are objective data
(objective measures). Conversely, the most relevant bias risks
in this review appeared to be random sequence generation or
selection bias, detection bias, and attrition bias.
Further studies should include male populations, unify
anatomical sites for determining bone mineralization, and
improve the blinding methods, although it is difficult to blind
dairy food supplementation, but the risk of bias would be
lower. Research comparing the effects of calcium from milk
with those of isolated calcium supplementation should be
continued.
Although no conclusive data exist relating the influence
of milk and dairy products to linear growth, data related to
improving bone mineralization after milk and milk product
supplementation indicate that dairy products are important
for proper bone health beginning in childhood.
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Conclusion
The data obtained in the present review support the dietary
guidelines (26) on the importance of children regularly
consuming dairy products to ensure or improve their bone
health. An increase of BMC is observed when the usual diet
is supplemented with dairy products. This is especially im-
portant during this period of life at a time when consumption
of this traditionally basic food in children’s diets, particularly
in Western countries, is decreasing due to lifestyle changes
that favor intake of fast food, soft drinks, or plant seed–
based beverages. Future research should be oriented towards
realizing randomized controlled trials of appropriate sample
size and adequate power, long-term interventions, and deep
analyses of cohort studies in children beginning in early life.
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